1. Home
  2. VERA vs SHOO Comparison

VERA vs SHOO Comparison

Compare VERA & SHOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$34.10

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Logo Steven Madden Ltd.

SHOO

Steven Madden Ltd.

HOLD

Current Price

$41.80

Market Cap

3.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
VERA
SHOO
Founded
2016
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Shoe Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.2B
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
VERA
SHOO
Price
$34.10
$41.80
Analyst Decision
Strong Buy
Buy
Analyst Count
10
7
Target Price
$81.30
$42.14
AVG Volume (30 Days)
2.0M
844.1K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
2.27%
EPS Growth
N/A
N/A
EPS
N/A
1.38
Revenue
N/A
$2,534,109,000.00
Revenue This Year
N/A
$12.39
Revenue Next Year
$472.48
$5.90
P/E Ratio
N/A
$31.29
Revenue Growth
N/A
11.00
52 Week Low
$21.71
$28.91
52 Week High
$56.05
$49.70

Technical Indicators

Market Signals
Indicator
VERA
SHOO
Relative Strength Index (RSI) 51.69 32.03
Support Level $33.43 $41.99
Resistance Level $42.77 $44.62
Average True Range (ATR) 1.74 0.98
MACD 0.50 -0.66
Stochastic Oscillator 66.17 5.79

Price Performance

Historical Comparison
VERA
SHOO

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About SHOO Steven Madden Ltd.

Steven Madden Ltd and its subsidiaries design, source, and market branded and private label footwear, accessories, and apparel. Its offerings include contemporary styles and core products, known for design creativity, trend-right offerings, high quality, and accessible price points. It operates through four segments: Wholesale Footwear, which generates maximum revenue and sells footwear globally; Wholesale Accessories/Apparel, which sells handbags and apparel through wholesale channels; Direct-to-Consumer, which sells footwear, handbags, apparel, and accessories through stores, outlets, e-commerce, and concessions; and Licensing, which licenses Steve Madden, Betsey Johnson, and Kurt Geiger trademarks, with the Company generating the majority of its revenue from the USA.

Share on Social Networks: